SARA SZYNAL: Open Payments
NPI 1710613591 · LA PORTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 28 payments from 7 companies in 2025. Trend: 2023 $460 · 2024 $266 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $278 |
| Boston Scientific Corporation | 3 | $101 |
| Medtronic, Inc. | 1 | $67 |
| Abbott Laboratories | 2 | $51 |
| Vital Connect, Inc | 2 | $46 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $31 |
| Merck Sharp & Dohme LLC | 1 | $23 |
Products named: LEQVIO, WATCHMAN FLX, COREVALVE EVOLUT R, CARDIOMEMS, VITALPATCH RTM, LifeVest, VERQUVO.
Industry payments across IN — which companies pay providers there.
